A coalition of state attorneys general filed suit against the Trump administration this week, challenging a federal rule that would cut off Medicare, Medicaid and Children's Health Insurance Program funding for gender-affirming care provided to anyone under 19. The states argue the rule oversteps federal authority and punishes a small, vulnerable population for political gain.
What the Lawsuit Argues
Filed in the U.S. District Court for the District of Massachusetts, the suit doesn't mince words about what it says is really happening. It describes the administration as seeking sweeping new powers partly to serve a broader political project, one built around what the filing calls relentless attacks on transgender people. The states contend Congress explicitly left decisions about what Medicaid and CHIP cover to the states themselves, and that HHS can't simply override that judgment by fiat.
The complaint also revives a familiar civil-rights argument: because cisgender patients can still get federal coverage for the very same treatments and procedures being denied to transgender patients, the rule amounts to discrimination based on sex. States say HHS cherry-picked evidence and never made a genuine case that gender-affirming care isn't medically necessary, contradicting both the agency's own precedent and the Social Security Act.
The federal government does not have the authority to dictate what medically necessary care New York provides to its residents.
Letitia James, New York Attorney General
California Attorney General Rob Bonta framed the fight in similarly sharp terms, saying HHS has disregarded the law and its own policy precedent in another attempt to restrict transgender people's access to care. He was careful to note the rule doesn't ban the care itself in states where it remains legal; it only blocks the use of federal dollars, leaving states free to keep paying with their own funds.
A Second Attempt After an Earlier Loss
This isn't the administration's first swing at gender-affirming care funding. Bonta joined roughly 18 other attorneys general in December 2025 to challenge an earlier HHS declaration on the same subject, and a federal judge struck that effort down in April. The administration appeared to abandon an appeal in July before returning with this narrower, funding-specific rule, which legal observers see as an attempt to achieve much the same result through a different lever.
The stakes go beyond paperwork. Trans journalist Erin Reed called the states' lawsuit the next major step in the fight to protect transgender health care, warning that losing federal funding could be devastating for hospital systems that rely on it. Reed has tracked more than 40 hospitals and health systems that have already paused or ended gender-affirming care programs under political pressure, even absent any federal law requiring them to do so, in some cases in apparent violation of state and local nondiscrimination protections.
The Bigger Picture
This fight is unfolding against a legal landscape that's shifted hard against transgender youth in the past two years. Twenty-seven states have already passed laws restricting minors' access to gender-affirming care since Arkansas became the first in 2021, and the Supreme Court's 2025 ruling in United States v. Skrmetti upheld Tennessee's ban, handing the administration a favorable precedent to lean on. At least 18 states and Washington, D.C. have gone the other direction, passing shield laws to protect patients and providers. That patchwork is exactly why a funding fight matters so much: it's a way for the federal government to reach into states that have chosen to protect this care and squeeze it anyway. Maryland's Medicaid program, for example, spent roughly $1.7 million on gender-affirming care visits in 2024, more than half of it federally funded money that would disappear under the new rule.
Why This Matters to Us
Every major medical association recognizes gender-affirming care as the standard of care for trans youth, and the evidence tying it to lower rates of depression and suicide isn't in serious scientific dispute. What's happening here isn't a debate about medicine; it's a debate about whether a small population can be priced out of care through bureaucratic maneuvering after courts already said no once. The comment period result, over 90% opposed out of tens of thousands of responses, tells you how little public appetite there was for this rule even before it was finalized largely unchanged. Whatever the outcome in Massachusetts, watch for hospitals to keep making decisions under duress long before a judge rules, since the mere threat of losing federal money is already reshaping care on the ground.
Sources: LGBTQ Nation, The Advocate
Cover photo: Mark Stebnicki / Pexels
